Enjoy complimentary customisation on priority with our Enterprise License!
The Hyperbaric Oxygen Therapy (HBOT) Market size is forecast to increase by USD 145.05 million, at a CAGR of 5.49% between 2023 and 2028.
There has been an increasing number of clinical trials sponsored by different universities and industry players which is significantly contributing to the advancement of HBOT research. In addition, clinical trials play a crucial role in assessing the safety and efficacy of HBOT across a range of medical conditions, driving innovation, and expanding its therapeutic applications. Moreover, universities are actively involved in conducting clinical trials to explore the potential benefits of HBOT in diverse medical fields. Hence, such factors are positively impacting the market growth.
Technavio has segmented the market into Type, Application, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
Monoplace hyperbaric chamber
The monoplace hyperbaric chamber segment is estimated to witness significant growth during the forecast period. Monoplace hyperbaric chambers refer to medical devices designed for HBOT, accommodating one patient at a time. In addition, they provide a pressurized environment for the administration of high-concentration oxygen for therapeutic purposes. Furthermore, this appeals to individuals who may prefer a more personalized treatment experience.
Get a glance at the market contribution of various segments Download PDF Sample
The monoplace hyperbaric chamber segment was the largest segment and was valued at USD 250.95 million in 2018. Moreover, monoplace hyperbaric chambers allow for precise control of oxygen concentration and pressure, tailoring treatments to the specific needs of individual patients. In addition, monoplace hyperbaric chambers are often more cost-effective to install and operate compared to multi-place chambers. Furthermore, this makes them a preferred choice for healthcare facilities looking to provide hyperbaric oxygen therapy while managing operational costs. In addition, monoplace chambers are simpler to operate and require less staff training, contributing to streamlined workflows in healthcare settings. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Diabetes, vascular diseases, and aging populations contribute to a global increase in chronic wounds, generating a vast patient pool in need of effective treatment options. In addition, HBOT's ability to promote tissue oxygenation, angiogenesis, and collagen production makes it a promising therapy for chronic wounds that often resist conventional treatments. Moreover, HBOT involves the administration of pure oxygen in a pressurized chamber, leading to a substantial increase in oxygen levels in the bloodstream. In addition, this heightened oxygen supply aids in cellular metabolism and accelerates the healing process. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Decompression sickness is a condition that can impact scuba divers and individuals participating in underwater activities. Thus, HBOT is a recognized and effective treatment for decompression sickness, offering a crucial intervention to improve diver safety. In addition, the decompression sickness application segment in the global hyperbaric oxygen therapy market is primarily driven by its efficacy in treating and preventing decompression sickness, also known as the bends. Moreover, decompression sickness occurs when inert gases, such as nitrogen, accumulate in the body during underwater activities. In addition, HBOT accelerates the elimination of these gases by increasing the atmospheric pressure, facilitating their removal from the body tissues and bloodstream. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The increasing prevalence of chronic wounds, including diabetic foot ulcers and pressure injuries, is a significant driver in the growth of the hyperbaric oxygen therapy (HBOT) market in North America. In addition, HBOT has proven efficacy in promoting wound healing, reducing the risk of infections, and preventing amputations. Moreover, there is an increasing awareness and acceptance of HBOT among healthcare professionals and patients. Furthermore, as an understanding of its therapeutic benefits expands, more medical facilities are incorporating HBOT into their treatment protocols. In addition, ongoing advancements in hyperbaric chamber technology enhance treatment efficacy, safety, and patient comfort is also driving the regional market. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Airox Technologies Ltd: The company offers hyperbaric oxygen therapy systems such as BAROX SOLO Half Acrylic.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the hyperbaric oxygen therapy market growth is the increasing incidence and prevalence of acute and chronic wounds. The rising incidence and prevalence of acute and chronic wounds are expected to increase the demand for HBOT. In addition, both chronic and acute wounds, such as diabetic foot ulcers, venous ulcers, pressure ulcers, burns, and traumatic ulcers, require HBOT. Furthermore, the market in focus has witnessed an increase in the incidence of the above-mentioned types of wounds.
Moreover, diabetes is associated with several serious complications. In addition, one of them is diabetic foot ulcers. Because of poor blood circulation and neuropathy in the feet, diabetic patients have the tendency to develop blisters, which can easily turn into ulcers that become infected. Furthermore, the prevalence of diabetes mellitus is expected to increase globally, and the number of diabetic patients is on the rise across the world. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the hyperbaric oxygen therapy market growth is the technological advancements in HBOT devices. Technological advancements in HBOT devices are fuelling the growth of the global hyperbaric oxygen therapy market, improving treatment efficacy, patient comfort, and overall safety. In addition, one notable technological innovation is the development of advanced hyperbaric chambers equipped with state-of-the-art control systems.
Moreover, these systems enable precise regulation of pressure and oxygen levels, ensuring optimal treatment conditions for patients. In addition, integrated monitoring and feedback mechanisms contribute to a safer and more personalized treatment experience. Furthermore, advancements in hyperbaric chamber design have led to the creation of portable and compact models. In addition, these devices offer greater flexibility in terms of installation and usage, making HBOT more accessible in various healthcare settings. Hence, such factors are driving the market growth during the forecast period.
The high cost of HBOT treatment is one of the key challenges hindering the hyperbaric oxygen therapy market growth. The expenses related to HBOT comprise not only the treatment sessions but also the infrastructure, equipment, and skilled personnel required to administer the therapy safely. In addition, one instance highlighting the cost challenge is the substantial investment in hyperbaric chambers.
Moreover, these pressurized chambers, where patients undergo HBOT, are specialized and come with a hefty price tag. In addition, hospitals and healthcare facilities need to allocate considerable financial resources to set up and maintain these chambers, making the overall cost of providing HBOT relatively high. Hence, such factors are negatively impacting the hyperbaric oxygen therapy market. Therefore, it is expected to hinder the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Hyperbaric Oxygen Therapy Market Customer Landscape
The hyperbaric oxygen therapy market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
|
Hyperbaric Oxygen Therapy Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.49% |
|
Market Growth 2024-2028 |
USD 145.05 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.21 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 32% |
|
Key countries |
US, UK, Germany, China, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Airox Technologies Ltd., Baroks AS, Biobarica, Environmental Tectonics Corp., Fink Engineering, Gulf Coast Hyperbarics Inc., Haux Life Support GmbH, Hipertech Inc., Hyperbaric Modular Systems Inc., Hyperbaric SAC, OxyHealth, Pan America Hyperbarics Inc., Perry Baromedical Corp., Richmond Hyperbaric Health Center, Royal IHC, Sechrist Industries Inc., Sosgroup, Tekna Hyperbaric, Unique Group, and HEARMEC |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
